BAKER BROS. ADVISORS LP 13D and 13G filings for Neoleukin Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 4:42 pm Purchase | 2023-10-05 | 13D | Neoleukin Therapeutics, Inc. NLTX | BAKER BROS. ADVISORS LP | 473,667 19.990% | 473,667 (New Position) | Filing |